在结肠直肠癌中准KRAS:床边审查的长椅
Fernand Bteich1,2, Mahshid Mohammadi2,3, Terence Li2,3
1Department of Medical Oncology, Montefiore Medical Center, Bronx, NY 10467, USA.
International journal of molecular sciences
|August 12, 2023
概括
针对结肠直肠癌 (CRC) 中的KRAS突变,新的抑制剂正在推进. 组合疗法对于克服KRAS突变CRC治疗中的耐药性至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 大肠直肠癌 (CRC) 是一种复杂的疾病,经常出现KRAS突变 (高达40%).
- KRAS突变通过RAS/MAPK途径驱动瘤发生,影响扩散和存活.
- 历史上,KRAS作为预后和预测生物标志物,直至最近,直接治疗向有限.
研究的目的:
- 审查目前对针对CRC中的KRAS突变的理解和发现.
- 探索对KRAS抑制剂耐药性的机制.
- 讨论KRAS突变的CRC.治疗策略的发展.
主要方法:
- 关于KRAS抑制剂的最新临床前和临床研究的综述.
- 对KRAS突变瘤的适应性抵抗机制的分析.
- 综合现有和新兴的治疗策略.
主要成果:
- 几种KRAS等位基特异性抑制剂正在临床试验的后期阶段.
- 新的代理和准策略正处于早期开发阶段.
- 由于强大的适应性抵抗,组合疗法是必不可少的.
结论:
- 向KRAS突变代表了CRC治疗的重大进展.
- 了解和克服抵抗机制对于有效治疗至关重要.
- 未来的CRC治疗可能会涉及对KRAS突变患者的组合策略.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


